Bojana Jovanović
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- Oncology top 5%
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 3
-
- Advanced Breast Cancer Therapies 4
-
- TGF-β signaling in diseases 4
- Molecular Biology Techniques and Applications 2
-
- Parasite Biology and Host Interactions 4
-
- Helminth infection and control 4
- Co-authors
- Harold L. MosesJennifer A. PietenpolBrian D. LehmannYu ShyrXi ChenKimberly N. JohnsonMónica V. EstradaMelinda E. Sanders
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Bojana Jovanović
21 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 571
- Oncology 745
- Pulmonary and Respiratory Medicine 294
- Molecular Biology 582
- Immunology 119
Countries citing papers authored by Bojana Jovanović
This map shows the geographic impact of Bojana Jovanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojana Jovanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojana Jovanović more than expected).
Fields of papers citing papers by Bojana Jovanović
This network shows the impact of papers produced by Bojana Jovanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojana Jovanović. The network helps show where Bojana Jovanović may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bojana Jovanović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2020 | 24 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 47 | |
| 8 | 2019 | 3 | |
| 9 | 2017 | 28 | |
| 10 | Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selectionbreakdown → | 2016 | 946 |
| 11 | 2016 | 10 | |
| 12 | 2014 | 45 | |
| 13 | 2013 | 42 | |
| 14 | 2011 | 87 | |
| 15 | 2010 | 33 | |
| 16 | 2010 | 11 | |
| 17 | 2008 | 3 | |
| 18 | 2005 | 5 | |
| 19 | 2005 | 10 | |
| 20 | 2005 | 50 |
About Bojana Jovanović
Bojana Jovanović is a scholar working on Small Animals, Oncology and Cancer Research, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Advanced Breast Cancer Therapies (4 papers), TGF-β signaling in diseases (4 papers), Parasite Biology and Host Interactions (4 papers), Cancer Genomics and Diagnostics (4 papers), Helminth infection and control (4 papers), Cancer-related Molecular Pathways (3 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (571 citations), Oncology (745 citations) and Pulmonary and Respiratory Medicine (294 citations). Bojana Jovanović has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Harold L. Moses, Jennifer A. Pietenpol, Brian D. Lehmann, Yu Shyr, Xi Chen, Kimberly N. Johnson, Mónica V. Estrada, Melinda E. Sanders, Andries Zijlstra and Agnieszka E. Gorska. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.